SXTC vs TLRY

Quick Summary — TLRY scores higher on quality with 6.8/10 vs SXTC's 1.1/10. SXTC trades at $1.78 while TLRY trades at $5.38. Both analyzed daily using SEC EDGAR data across 13 institutional models.

SXTC vs TLRY — Which Stock Is More Undervalued in 2026?

TLRY scores higher with a 6.8/10 quality rating vs SXTC's 1.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do SXTC and TLRY Valuations Compare?

At $1.78, SXTC trades +86.8% above its Bayesian DCF fair value of $0.23, while TLRY at $5.38 trades +71.5% above its estimate of $1.53. SXTC shows a wider gap between price and intrinsic value.

Quality of Company: SXTC vs TLRY

SXTC earns a Quality of Company score of 1.1/10 compared to TLRY's 6.8/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: SXTC vs TLRY

SXTC carries a SAFE value trap risk (15/100) while TLRY shows WARN risk (45/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.

Both in Drug Manufacturers - Specialty & Generic

Both SXTC and TLRY operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).